Susquehanna International Group, LLP Adma Biologics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

20 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$11.21 - $20.03 $1.73 Million - $3.09 Million	154,100 Added 37.29%	567,400 $11.3 Million
Q2 2024 Aug 15, 2024	BUY	$5.98 - $11.18 $2.1 Million - $3.93 Million	351,600 Added 569.85%	413,300 $4.62 Million
Q1 2024 May 07, 2024	BUY	$4.4 - $6.74 $65,560 - $100,426	14,900 Added 31.84%	61,700 $407,000
Q4 2023 Feb 14, 2024	SELL	$3.08 - $4.52 $8,008 - $11,751	-2,600 Reduced 5.26%	46,800 $211,000
Q3 2023 Nov 14, 2023	SELL	$3.47 - $4.61 $158,926 - $211,138	-45,800 Reduced 48.11%	49,400 $176,000
Q2 2023 Aug 11, 2023	BUY	$3.12 - $4.22 $15,288 - $20,678	4,900 Added 5.43%	95,200 $351,000
Q1 2023 May 16, 2023	BUY	$3.01 - $3.87 $33,712 - $43,344	11,200 Added 14.16%	90,300 $298,000
Q4 2022 Feb 14, 2023	SELL	$2.47 - $3.88 $127,946 - $200,984	-51,800 Reduced 39.57%	79,100 $306,000
Q3 2022 Nov 14, 2022	BUY	$2.03 - $2.86 $86,274 - $121,550	42,500 Added 48.08%	130,900 $318,000
Q2 2022 Aug 15, 2022	BUY	$1.43 - $2.2 $3,861 - $5,940	2,700 Added 3.15%	88,400 $175,000
Q1 2022 May 16, 2022	BUY	$1.28 - $1.83 $79,872 - $114,192	62,400 Added 267.81%	85,700 $157,000
Q4 2021 Feb 14, 2022	SELL	$1.09 - $1.66 $12,971 - $19,754	-11,900 Reduced 33.81%	23,300 $33,000
Q3 2021 Nov 15, 2021	SELL	$1.13 - $1.65 $19,322 - $28,215	-17,100 Reduced 32.7%	35,200 $40,000
Q2 2021 Aug 11, 2021	SELL	$1.51 - $2.07 $19,026 - $26,081	-12,600 Reduced 19.41%	52,300 $84,000
Q1 2021 May 17, 2021	BUY	$1.67 - $2.95 $35,237 - $62,245	21,100 Added 48.17%	64,900 $114,000
Q4 2020 Feb 16, 2021	SELL	$1.8 - $2.56 $152,820 - $217,344	-84,900 Reduced 65.97%	43,800 $85,000
Q3 2020 Nov 16, 2020	BUY	$2.04 - $3.74 $221,544 - $406,164	108,600 Added 540.3%	128,700 $308,000
Q1 2020 May 15, 2020	BUY	$1.5 - $4.59 $6,750 - $20,655	4,500 Added 28.85%	20,100 $58,000
Q2 2019 Aug 14, 2019	SELL	$3.52 - $5.24 $61,600 - $91,700	-17,500 Reduced 52.87%	15,600 $60,000
Q1 2019 May 15, 2019	BUY	$2.61 - $4.35 $86,391 - $143,985	33,100 New	33,100 $125,000

Others Institutions Holding ADMA

# of Institutions

317

Shares Held

185M

Call Options Held

917K

Put Options Held

91.6K

View Full List

About ADMA BIOLOGICS, INC.

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.74B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

More about ADMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account